Literature DB >> 24872787

Untangling the dravet syndrome seizure network: the changing face of a rare genetic epilepsy.

Ravi Chopra1, Lori L Isom2.   

Abstract

Dravet syndrome (also known as Severe Myoclonic Epilepsy of Infancy) is a rare genetic epilepsy syndrome commonly associated with loss-of-function mutations in SCN1A, the gene encoding the α subunit of the voltage-gated sodium channel NaV1.1, resulting in haploinsufficiency. Like other voltage-gated sodium channels, NaV1.1 function contributes to the rising phase of the neuronal action potential; thus, the observation that loss-of-function mutations in this channel gene are associated with seizures has created a paradox for the field. Major work has been done to untangle this paradox during the past decade, resulting in the development of two distinct hypotheses to explain seizures in Dravet syndrome. Here, we review the history of these two hypotheses and speculate as to what the history of Dravet syndrome research might tell us about its future.

Entities:  

Year:  2014        PMID: 24872787      PMCID: PMC4010885          DOI: 10.5698/1535-7597-14.2.86

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  29 in total

1.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

Authors:  L Claes; J Del-Favero; B Ceulemans; L Lagae; C Van Broeckhoven; P De Jonghe
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

2.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

Review 3.  The core Dravet syndrome phenotype.

Authors:  Charlotte Dravet
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

4.  A functional null mutation of SCN1B in a patient with Dravet syndrome.

Authors:  Gustavo A Patino; Lieve R F Claes; Luis F Lopez-Santiago; Emily A Slat; Raja S R Dondeti; Chunling Chen; Heather A O'Malley; Charles B B Gray; Haruko Miyazaki; Nobuyuki Nukina; Fumitaka Oyama; Peter De Jonghe; Lori L Isom
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

5.  The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.

Authors:  Melinda S Martin; Bin Tang; Ligia A Papale; Frank H Yu; William A Catterall; Andrew Escayg
Journal:  Hum Mol Genet       Date:  2007-09-19       Impact factor: 6.150

6.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

Authors:  Tateki Fujiwara; Takashi Sugawara; Emi Mazaki-Miyazaki; Yukitoshi Takahashi; Katsuyuki Fukushima; Masako Watanabe; Keita Hara; Tateki Morikawa; Kazuichi Yagi; Kazuhiro Yamakawa; Yushi Inoue
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

7.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy.

Authors:  R Nabbout; E Gennaro; B Dalla Bernardina; O Dulac; F Madia; E Bertini; G Capovilla; C Chiron; G Cristofori; M Elia; E Fontana; R Gaggero; T Granata; R Guerrini; M Loi; L La Selva; M L Lispi; A Matricardi; A Romeo; V Tzolas; D Valseriati; P Veggiotti; F Vigevano; L Vallée; F Dagna Bricarelli; A Bianchi; F Zara
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons.

Authors:  Jocelyn F Krey; Sergiu P Paşca; Aleksandr Shcheglovitov; Masayuki Yazawa; Rachel Schwemberger; Randall Rasmusson; Ricardo E Dolmetsch
Journal:  Nat Neurosci       Date:  2013-01-13       Impact factor: 24.884

10.  Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome.

Authors:  Ikuo Ogiwara; Takuji Iwasato; Hiroyuki Miyamoto; Ryohei Iwata; Tetsushi Yamagata; Emi Mazaki; Yuchio Yanagawa; Nobuaki Tamamaki; Takao K Hensch; Shigeyoshi Itohara; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2013-08-06       Impact factor: 6.150

View more
  15 in total

1.  Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.

Authors:  P Kurbatova; F Wendling; A Kaminska; A Rosati; R Nabbout; R Guerrini; O Dulac; G Pons; C Cornu; P Nony; C Chiron; P Benquet
Journal:  Exp Neurol       Date:  2016-05-28       Impact factor: 5.330

2.  Serotonergic agents act on 5-HT3 receptors in the brain to block seizure-induced respiratory arrest in the DBA/1 mouse model of SUDEP.

Authors:  Carl L Faingold; Marcus Randall; Chang Zeng; Shifang Peng; Xiaoyan Long; Hua-Jun Feng
Journal:  Epilepsy Behav       Date:  2016-10-12       Impact factor: 2.937

Review 3.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

4.  5-Hydroxytryptophan, a precursor for serotonin synthesis, reduces seizure-induced respiratory arrest.

Authors:  Honghai Zhang; Haiting Zhao; Xiaoxuan Yang; Qingsheng Xue; Joseph F Cotten; Hua-Jun Feng
Journal:  Epilepsia       Date:  2016-06-15       Impact factor: 5.864

Review 5.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

6.  Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity.

Authors:  Stefania Scalise; Clara Zannino; Valeria Lucchino; Michela Lo Conte; Luana Scaramuzzino; Pierangelo Cifelli; Tiziano D'Andrea; Katiuscia Martinello; Sergio Fucile; Eleonora Palma; Antonio Gambardella; Gabriele Ruffolo; Giovanni Cuda; Elvira Immacolata Parrotta
Journal:  Biomedicines       Date:  2022-05-05

7.  Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Authors:  Reesha R Patel; Cindy Barbosa; Tatiana Brustovetsky; Nickolay Brustovetsky; Theodore R Cummins
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

Review 8.  Voltage-Gated Na+ Channels: Not Just for Conduction.

Authors:  Larisa C Kruger; Lori L Isom
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

9.  Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.

Authors:  Karen S Ho; Sarah T South; Amanda Lortz; Charles H Hensel; Mallory R Sdano; Rena J Vanzo; Megan M Martin; Andreas Peiffer; Christophe G Lambert; Amy Calhoun; John C Carey; Agatino Battaglia
Journal:  J Med Genet       Date:  2016-01-08       Impact factor: 6.318

10.  An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy.

Authors:  Jacob P Miller; Hans J Moldenhauer; Sotirios Keros; Andrea L Meredith
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.